Publications by authors named "Douglas Wolf"

Claim this Profile
E
Enhancing pesticide risk assessment processes at the US Environmental Protection Agency.
Gina M Hilton, Penelope A Fenner-Crisp, William L Jordan, Amy J Clippinger, Douglas C Wolf

Regul Toxicol Pharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Stefan Schreiber, Scott D Lee, C Janneke van der Woude, Ignacio Marín-Jiménez, Douglas C Wolf

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming the Evaluation of Agrochemicals: A Conceptual Model.
Bhuller Yadvinder, Bishop Patricia, Cope Rhian, Corvaro Marco, Richard A Currie, Douglas C Wolf

Regul Toxicol Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
Bruce E Sands, David T Rubin, Edward V Loftus, Douglas C Wolf, Remo Panaccione

Am J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and Volatility in the Contextual Predictors of Working-Age Mortality in the United States.
Jennifer Karas Montez, Shannon M Monnat, Emily E Wiemers, Douglas A Wolf, Xue Zhang

J Health Soc Behav· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policy Brief.
Jennifer Karas Montez, Shannon M Monnat, Emily E Wiemers, Douglas A Wolf, Xue Zhang

J Health Soc Behav· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry.
Sara Lewin, Millie Long, Russell Cohen, Ellen Scherl, Douglas Wolf

Inflamm Bowel Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building Survey Data Infrastructure on Aging: The Legacy of NIA.
Emily M Agree, Amanda Sonnega, Douglas A Wolf

Gerontologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.
Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, Geert R D'Haens, Julian Panés, Douglas C Wolf

J Crohns Colitis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paid Leave Mandates and Care for Older Parents.
Kanika Arora, Douglas A Wolf

Milbank Q· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER).
Jean-Frederic Colombel, Ryan C Ungaro, Bruce E Sands, Corey A Siegel, Douglas C Wolf

Clin Gastroenterol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State COVID-19 Policies and Drug Overdose Mortality Among Working-Age Adults in the United States, 2020.
Douglas A Wolf, Shannon M Monnat, Emily E Wiemers, Yue Sun, Xue Zhang

Am J Public Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
Sarah Harris, Brian G Feagan, Stephen Hanauer, Severine Vermeire, Subrata Ghosh, Douglas C Wolf

Dig Dis Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing human carcinogenicity risk of agrochemicals without the rodent cancer bioassay.
Amber Goetz, Natalia Ryan, Alaina Sauve-Ciencewicki, Caleb C Lord, Gina M Hilton, Douglas C Wolf

Front Toxicol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses.
Alessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, Jason Hou, Parakkal Deepak, Douglas C Wolf

Clin Gastroenterol Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Approach to Integrate Human Biomonitoring Data with Model Predicted Dietary Exposures: A Crop Protection Chemical Case Study Using Lambda-Cyhalothrin.
Nicholas Cuvelier, Raga Avanasi, Mark Grunenwald, Tharacad Ramanarayanan, Douglas C Wolf

J Agric Food Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Changing Demography of Late-Life Family Caregiving: A Research Agenda to Understand Future Care Networks for an Aging U.S. Population.
Vicki A Freedman, Emily M Agree, Judith A Seltzer, Kira S Birditt, Karen L Fingerman, Douglas A Wolf, Jennifer L Wolff

Gerontologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Silvio Danese, Remo Panaccione, Maria T Abreu, David T Rubin, Subrata Ghosh, Douglas C Wolf

J Crohns Colitis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing prototypes of a modernized approach to assess crop protection chemical safety.
Richard A Currie, John Abbott, David A Dreier, Haitian Lu, Tharacad Ramanarayanan, Douglas C Wolf

ALTEX· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new paradigm for regulatory sciences.
Gina M Hilton, Yadvinder Bhuller, John E Doe, Douglas C Wolf, Richard A Currie

Regul Toxicol Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. States' COVID-19 physical distancing policies and working-age adult mental health outcomes.
Shannon M Monnat, David C Wheeler, Emily Wiemers, Yue Sun, Xinxin Sun, Douglas A Wolf

Prev Med Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies.
William J Sandborn, Jingjing Chen, Krisztina Kisfalvi, Edward V Loftus, Geert D'Haens, Douglas C Wolf

Crohns Colitis 360· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in Urgency Status Among Ulcerative Colitis Patients: Understanding a Potential Unmet Patient Need From the CorEvitas Inflammatory Bowel Disease Registry.
Douglas C Wolf, April N Naegeli, Page C Moore, Jud C Janak, Margaux M Crabtree

Gastro Hep Adv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the 90-day dog study necessary for pesticide toxicity testing?
Patricia L Bishop, Vicki L Dellarco, Douglas C Wolf

Crit Rev Toxicol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis